Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 159

1.

Serum placental growth factor as a predictor of early onset preeclampsia in overweight/obese pregnant women.

Ghosh SK, Raheja S, Tuli A, Raghunandan C, Agarwal S.

J Am Soc Hypertens. 2013 Mar-Apr;7(2):137-48. doi: 10.1016/j.jash.2012.12.006. Epub 2013 Feb 6.

PMID:
23394804
2.

Is serum placental growth factor more effective as a biomarker in predicting early onset preeclampsia in early second trimester than in first trimester of pregnancy?

Ghosh SK, Raheja S, Tuli A, Raghunandan C, Agarwal S.

Arch Gynecol Obstet. 2013 May;287(5):865-73. doi: 10.1007/s00404-012-2662-2. Epub 2012 Dec 7.

PMID:
23224699
3.

Can maternal serum placental growth factor estimation in early second trimester predict the occurrence of early onset preeclampsia and/or early onset intrauterine growth restriction? A prospective cohort study.

Ghosh SK, Raheja S, Tuli A, Raghunandan C, Agarwal S.

J Obstet Gynaecol Res. 2013 May;39(5):881-90. doi: 10.1111/jog.12006. Epub 2013 Mar 17.

PMID:
23496304
4.

Vasoactive agents for the prediction of early- and late-onset preeclampsia in a high-risk cohort.

Villa PM, Hämäläinen E, Mäki A, Räikkönen K, Pesonen AK, Taipale P, Kajantie E, Laivuori H.

BMC Pregnancy Childbirth. 2013 May 12;13:110. doi: 10.1186/1471-2393-13-110.

5.

Screening models using multiple markers for early detection of late-onset preeclampsia in low-risk pregnancy.

Park HJ, Kim SH, Jung YW, Shim SS, Kim JY, Cho YK, Farina A, Zanello M, Lee KJ, Cha DH.

BMC Pregnancy Childbirth. 2014 Jan 20;14:35. doi: 10.1186/1471-2393-14-35.

6.

A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia.

Kusanovic JP, Romero R, Chaiworapongsa T, Erez O, Mittal P, Vaisbuch E, Mazaki-Tovi S, Gotsch F, Edwin SS, Gomez R, Yeo L, Conde-Agudelo A, Hassan SS.

J Matern Fetal Neonatal Med. 2009 Nov;22(11):1021-38. doi: 10.3109/14767050902994754.

7.

Identification of patients at risk for early onset and/or severe preeclampsia with the use of uterine artery Doppler velocimetry and placental growth factor.

Espinoza J, Romero R, Nien JK, Gomez R, Kusanovic JP, Gonçalves LF, Medina L, Edwin S, Hassan S, Carstens M, Gonzalez R.

Am J Obstet Gynecol. 2007 Apr;196(4):326.e1-13. Erratum in: Am J Obstet Gynecol. 2007 Jun;196(6):614.

8.

Combination of uterine artery Doppler velocimetry and maternal serum placental growth factor estimation in predicting occurrence of pre-eclampsia in early second trimester pregnancy: a prospective cohort study.

Ghosh SK, Raheja S, Tuli A, Raghunandan C, Agarwal S.

Eur J Obstet Gynecol Reprod Biol. 2012 Apr;161(2):144-51. doi: 10.1016/j.ejogrb.2011.12.031. Epub 2012 Jan 27.

PMID:
22280827
9.

[Value of second trimester maternal serum sFlt-1, PlGF and their ratio in the prediction of preeclampsia].

Gao J, Shen J, Jiang Y, Zhou X, Qi H, Liu X, Liu J, Yang J, Bian X.

Zhonghua Fu Chan Ke Za Zhi. 2014 Jan;49(1):22-5. Chinese.

PMID:
24694913
10.

Changes in circulating concentrations of soluble fms-like tyrosine kinase-1 and placental growth factor measured by automated electrochemiluminescence immunoassays methods are predictors of preeclampsia.

Leaños-Miranda A, Campos-Galicia I, Isordia-Salas I, Rivera-Leaños R, Romero-Arauz JF, Ayala-Méndez JA, Ulloa-Aguirre A.

J Hypertens. 2012 Nov;30(11):2173-81. doi: 10.1097/HJH.0b013e328357c0c9.

PMID:
22902831
11.

Endoglin, PlGF and sFlt-1 as markers for predicting pre-eclampsia.

De Vivo A, Baviera G, Giordano D, Todarello G, Corrado F, D'anna R.

Acta Obstet Gynecol Scand. 2008;87(8):837-42. doi: 10.1080/00016340802253759.

PMID:
18607829
13.

Placental growth factor and soluble FMS-like tyrosine kinase-1 in early-onset and late-onset preeclampsia.

Wikström AK, Larsson A, Eriksson UJ, Nash P, Nordén-Lindeberg S, Olovsson M.

Obstet Gynecol. 2007 Jun;109(6):1368-74.

PMID:
17540809
14.

Serum PLGF as a potential biomarker for predicting the onset of preeclampsia.

Ghosh SK, Raheja S, Tuli A, Raghunandan C, Agarwal S.

Arch Gynecol Obstet. 2012 Feb;285(2):417-22. doi: 10.1007/s00404-011-1960-4. Epub 2011 Jul 7.

PMID:
21735190
15.

Second-trimester maternal serum placental growth factor and vascular endothelial growth factor for predicting severe, early-onset preeclampsia.

Polliotti BM, Fry AG, Saller DN, Mooney RA, Cox C, Miller RK.

Obstet Gynecol. 2003 Jun;101(6):1266-74.

PMID:
12798535
16.

Decreased maternal serum placenta growth factor in early second trimester and preeclampsia.

Su YN, Lee CN, Cheng WF, Shau WY, Chow SN, Hsieh FJ.

Obstet Gynecol. 2001 Jun;97(6):898-904.

PMID:
11384693
17.

Repeated measures of placental growth factor, placental protein 13, and a disintegrin and metalloprotease 12 at first and second trimesters for preeclampsia screening.

Boucoiran I, Suarthana E, Rey E, Delvin E, Fraser WB, Audibert F.

Am J Perinatol. 2013 Sep;30(8):681-8. doi: 10.1055/s-0032-1331025. Epub 2013 Feb 5.

PMID:
23386402
18.

Circulating angiogenic factors and the risk of preeclampsia.

Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, Schisterman EF, Thadhani R, Sachs BP, Epstein FH, Sibai BM, Sukhatme VP, Karumanchi SA.

N Engl J Med. 2004 Feb 12;350(7):672-83. Epub 2004 Feb 5.

19.

Soluble Fms-like tyrosine kinase-1 to placental growth factor ratio in mid-pregnancy as a predictor of preterm preeclampsia in asymptomatic pregnant women.

Forest JC, Thériault S, Massé J, Bujold E, Giguère Y.

Clin Chem Lab Med. 2014 Aug;52(8):1169-78. doi: 10.1515/cclm-2013-0955.

PMID:
24535301
20.

First-Trimester Maternal Serum Levels of sFLT1, PGF and ADMA Predict Preeclampsia.

Bian Z, Shixia C, Duan T.

PLoS One. 2015 Apr 23;10(4):e0124684. doi: 10.1371/journal.pone.0124684. eCollection 2015.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk